Constipation Relief: Understanding Osmotic Laxatives and Their Effects

Do you struggle with constipation? It can be caused by various factors like irritable bowel syndrome (IBS), long-term opioid use, or even chemotherapy. One of the most commonly recommended treatments for constipation is an osmotic laxative, such as Miralax, which contains polyethylene glycol 3350 (PEG 3350). But how exactly do these work, and what should you know about their effects?

How Osmotic Laxatives Work

Osmotic laxatives help relieve constipation by drawing water into your intestines, softening your stool, and making it easier to pass. PEG 3350 is one of the most popular options in the U.S. and is considered safe for short-term use. However, higher doses can sometimes cause watery stools or diarrhea by pulling in too much water.

Impact on the Gut Microbiome

Your gut is home to trillions of bacteria that play a key role in digestion, metabolism, and overall health—this collection of bacteria is known as the gut microbiome. Diarrhea can disrupt this balance, and since PEG 3350 can cause mild diarrhea, it may affect your gut bacteria as well.

Recent studies in animals have shown that even mild diarrhea from PEG 3350 can cause lasting changes in the gut microbiome. Some types of bacteria decreased during PEG treatment, but returned to normal a week after stopping. Other bacteria disappeared completely and didn’t return, while new bacteria emerged during treatment and declined afterward. The treatment also thinned the protective mucus lining in the intestines, leaving them exposed to bacteria.

Additionally, changes in the gut bacteria were linked to immune system responses, with an increase in certain immune proteins. Another study found that PEG 3350 increased levels of a specific bacterium, Akkermansia, which has been associated with anxiety-like behaviors in animals. Though more research is needed, this suggests that PEG 3350 may have subtle effects on mental health due to the close connection between the gut and the brain.

Potential Risks: C. difficile Infections

There is some concern that long-term use of PEG 3350 could make people more vulnerable to harmful bacteria, such as Clostridioides difficile (C. difficile), which can cause severe diarrhea and colitis. Studies in animals have shown that PEG 3350 can disrupt the balance of gut bacteria enough to increase susceptibility to infections like C. difficile, even after treatment ends. This raises questions about the long-term safety of using osmotic laxatives.

What Should You Do?

If you’re using osmotic laxatives regularly to manage constipation, it’s important to discuss other treatment options with your doctor. A registered dietitian can also help you develop a personalized plan that includes dietary changes to naturally relieve constipation, reducing the need for laxatives.

Maintaining a healthy gut is essential for your overall well-being, so it’s worth exploring other approaches to managing constipation, especially if you’re concerned about the long-term effects of laxative use.

1. _{Salman, S. S., Williams, K. C., Marte-Ortiz, P., Rumpf, W., Mashburn-Warren, L., Lauber, C. L., Bailey, M. T., & Maltz, R. M. (2021). Polyethylene Glycol 3350 Changes Stool Consistency and the Microbiome but not Behavior of CD1 Mice. Journal of pediatric gastroenterology and nutrition, 73(4), 499–506. https://doi.org/10.1097/MPG.0000000000003222}  
2. _{Tomkovich, S., Taylor, A., King, J., Colovas, J., Bishop, L., McBride, K., Royzenblat, S., Lesniak, N. A., Bergin, I. L., & Schloss, P. D. (2021). An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance. mSphere, 6(5), e0062921. https://doi.org/10.1128/mSphere.00629-21}  
3. _{Tropini, C., Moss, E. L., Merrill, B. D., Ng, K. M., Higginbottom, S. K., Casavant, E. P., Gonzalez, C. G., Fremin, B., Bouley, D. M., Elias, J. E., Bhatt, A. S., Huang, K. C., & Sonnenburg, J. L. (2018). Transient Osmotic Perturbation Causes Long-Term Alteration to the Gut Microbiota. Cell, 173(7), 1742–1754.e17. https://doi.org/10.1016/j.cell.2018.05.008}